Excerpt from article:
“Although the two therapy regimens were equally effective in reducing patients’ disease activity overall, our results indicate that rituximab is superior to cyclophosphamide in inducing remission for patients experiencing a disease flare,” comments Dr. Specks.
Read the full article here.
My Analysis: Finally a drug regimen that can help folks who flare on the disease. Even though rituximab does have side-effects, they are less harsh than cyclophosphamide (used to be called cytoxan). I am extremely excited about this research.
From talking to people who have taken this treatment, in most cases the vasculitis subsides quickly with little organ damage. In my case I have a lot of kidney damage caused by the disease. Some of the damage was caused while the doctors were trying to get the disease under control.
I am so happy and hope more researchers work with this drug so that we can use it to keep our disease under control. At this time rituximab is not considered a treatment drug for ANCA type vasculitis i.e. Wegener’s, Churg Strauss, and others.